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Chlamydophila (formerly  Chlamydia)  psittaci geno-
types A, B, C, and a new genotype most similar to the 6BC
type strain were found in 10 humans with psittacosis by
outer membrane protein A gene sequencing. Genotypes B
(n = 3) and C (n = 1) are endemic in nonpsittacine
European birds. These birds may represent an important
part of the zoonotic reservoir.
P
sittacosis is a zoonosis caused by infection with
Chlamydophila (formerly Chlamydia) psittaci, an obli-
gate intracellular bacterium. C. psittaci is divided into 8
serovars (A–F, M56, and WC) and at least 9 genotypes.
Sequence analysis of the outer membrane protein A
(ompA) gene is the most accurate method for identifying
all known genotypes (1). All genotypes are associated with
specific bird groups from which they are predominantly
isolated (2,3). The prevalence of different genotypes of C.
psittaci that cause infection in humans is unknown. In this
study, we genotyped all C. psittaci PCR-positive human
samples available in our laboratory.
The Study
Ten human samples positive for C. psittaci DNA in our
previously described real-time PCR assay were character-
ized by ompA gene sequencing (4). These samples were
collected from 2002 through 2005 and included 4 sputum,
4 bronchoalveolar lavage, 1 throat swab, and 1 serum. All
samples were obtained from symptomatic psittacosis
patients admitted to hospitals in the Netherlands. All
patients had pneumonia, and 6 required treatment in an
intensive care unit. The DNA of 1 outbreak strain, which
infected as many as 10 people, was tested only once in this
study. One of the samples was obtained from a patient who
has been previously described (5)
DNA purification was performed by using the guani-
dinium thiocyanate–silica extraction procedure (6).
Genotyping was performed essentially as previously
described (7). Briefly, a part of the ompA gene was ampli-
fied with primers CPsittGenoFor (5′-GCTACG GGTTCC
GCT CT-3′) and CPsittGenoRev (5′-TTT GTT GAT YTG
AAT CGAAGC-3′). These primers are located in the con-
served regions of the ompA gene that contains the 4 vari-
able domains (VDs). On the basis of published ompA
sequence of the C. psittaci 6BC type strain (GenBank
accession no. X56980), the resulting amplicon should have
a size of 1,041 bp. PCR products were analyzed by agarose
gel electrophoresis, and the expected 1,041-bp amplicon
was excised from the gel. DNAwas extracted from the gel
and reamplified for 20 cycles, and amplicons were ana-
lyzed for size by agarose gel electrophoresis. C. psittaci
ORNI (genotype A) strain and a C. abortus strain were
used as positive controls. Calf thymus DNA was used as a
negative control.
If the ompA gene could not be amplified with this pro-
cedure, a nested PCR with primers CPsittFinner (5′-CGC
TCT CTC CTT ACA AGC C-3′) and CPsittRinner (5′-
GAT CTG AAT CGA AGC AAT TTG-3′) was used. The
amplified product (n = 8) or the nested PCR product (n =
2) were subjected to sequence analysis (BigDye
Terminator, version 1.1, cycle sequencing kit, Applied
Biosystems, Foster City, CA, USA). Overlapping
sequences were obtained with 6 sequencing primers:
CPsittGenoFor and CPsittGenoRev, inner primers
CPsittFinner and CPsittRinner, and primers CPsittHFor
(5′-TCT TGG AGC GTR GGT GC-3′) and CPsittHRev
(5′-GCA CCYACG CTC CAA GA-3′). 
The resulting sequences were aligned, and a similarity
index based on the translation of the 984-bp gene fragment
was calculated. Similarity (1 – distance) was calculated by
using the pairwise distance method generated by MEGA3
(8). Reference ompA genotype sequences A–F and the
ompA sequence of the C. psittaci 6BC type strain available
in GenBank (accession nos. AY762608–AY762612,
X56980, and AF269261) were included in this analysis
(1,9).
All 10 isolates could be genotyped. The ompA sequence
of 5 isolates was identical to the sequence of reference
genotype A, 3 isolates were identical to genotype B, and
the ompA sequence of 1 isolate was identical to genotype
C. One isolate had a novel ompA sequence type that was
99.4% similar to the genotype A reference but more simi-
lar to the C. psittaci 6BC type strain (99.7%). Two nonsyn-
onymous mutations were present in this sequence
compared with reference genotype A. A substitution of
thymine for adenine in VD 1 resulted in Ser instead of Thr
at amino acid position 92 of the ompA amino acid
sequence, which is identical to that found in genotype C. A
substitution of cytosine for guanine, also located in VD 1,
resulted in Gln instead of Glu at amino acid position 117,
as found in genotype B and strain 6BC (numbering accord-
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6BC strain, GenBank accession no. X56980). We designat-
ed this new variant C. psittaci 05/02 and deposited the
sequence in GenBank (accession no DQ324426). Two
genotype B strains, 3 genotype A strains, and the novel
genotype 05/02 strain were obtained from patients admit-
ted to an intensive care unit.
Conclusions
To our knowledge, ours is the first report of a series of
genotyped C. psittaci strains isolated from symptomatic,
hospitalized patients. These 10 samples reflect approxi-
mately one third of all cases reported each year in the
Netherlands (10). From the genotypes that we identified,
we may infer the zoonotic reservoirs of C. psittaci in the
Netherlands. The different genotypes of C. psittaci are
associated, although not exclusively, with different birds
from which they are mostly isolated. Genotype A is main-
ly found in psittacine birds and was the most prevalent
genotype in our samples (1,3). C. psittaci 05/02 was most
related to C. psittaci 6BC and the reference genotype A
(strain VS1). Both reference strains have been classified as
serovar A strains. On the basis of 2 restriction fragment
length polymorphism patterns, Sayada et al. suggested that
serovar A should be divided into 2 genogroups (2). Our
isolate 05/02 is a new ompA gene sequence variant within
this probably heterogeneous group.
Genotype B has been isolated mainly from feral
pigeons and several other bird species; this genotype is
considered endemic in European nonpsittacine birds
(3,11). Genotype C has been isolated mainly from ducks,
and we detected this genotype in 1 of our human samples.
We did not find genotype D, which is prevalent among
poultry, especially turkeys, or genotypes E and F. These
last 2 genotypes are rare and found occasionally in birds
(1,11). Imported psittacine birds, which carry mainly geno-
type A, have been proposed as the major source for human
psittacosis infections (12). In our study, 4 of 10 isolates
were genotypes B and C, which are rarely found in
psittacine birds. This finding suggests that nonpsittacine
birds may represent an underestimated source for human
psittacosis cases.
We detected isolates of genotypes A, B, C, and a new
genotype similar to the C. psittaci 6BC strain in a series of
10 C. psittaci–positive samples. Genotypes B and C are
endemic in European nonpsittacine birds, which may rep-
resent an important part of the zoonotic reservoir for
human psittacosis cases.
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